Literature DB >> 10928647

Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.

G R Warnick1.   

Abstract

Measurements of lipids and lipoproteins in the clinical laboratory have become increasingly important because of their predictive association with cardiovascular diseases, especially coronary artery disease. The US National Institutes of Health-sponsored National Cholesterol Education Program and counterparts in other countries have developed national consensus guidelines for diagnosis and treatment of coronary artery disease which provide risk cut-points and define use of the lipid/lipoprotein analytes in case finding and therapy. Total and low density lipoprotein cholesterol and triglycerides are measured as positive risk factors and high density lipoprotein cholesterol as an inverse risk factor for coronary artery disease. A National Cholesterol Education Program-sponsored expert laboratory panel has developed guidelines for measurements with requisite analytical performance targets for total error and corresponding precision and bias. The US Centers for Disease Control and Prevention have established reference methods for total and high density lipoprotein cholesterol and for triglycerides, with a method for low density lipoprotein cholesterol in development. Standardization programs for research laboratories and a Cholesterol Reference Method Laboratory Network for diagnostic manufacturers and clinical laboratories provide reliable access and documentation of traceability to accepted reference methods. Methods for the lipid/lipoprotein analytes have improved dramatically in recent years and, coupled with improved chemistry analyzer systems and more attention to standardization by manufacturers, offer considerable improvement in analytical performance. Fully automated homogeneous assays for high density lipoprotein cholesterol and newer similar assays for low-density lipoprotein cholesterol have potential for better precision as well as more convenient and cost-effective measurements. Attention to pre-analytical sources of variation is also important in making reliable classification of patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928647     DOI: 10.1515/CCLM.2000.041

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Dulce Mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes.

Authors:  Athena Philis-Tsimikas; Addie L Fortmann; Sapna Dharkar-Surber; Johanna A Euyoque; Monica Ruiz; James Schultz; Linda C Gallo
Journal:  Transl Behav Med       Date:  2014-03       Impact factor: 3.046

2.  Trait anger, cynical hostility and inflammation in Latinas: variations by anger type?

Authors:  S Shivpuri; L C Gallo; P J Mills; K A Matthews; J P Elder; G A Talavera
Journal:  Brain Behav Immun       Date:  2011-05-01       Impact factor: 7.217

3.  Socioeconomic status, psychosocial resources and risk, and cardiometabolic risk in Mexican-American women.

Authors:  Linda C Gallo; Addie L Fortmann; Scott C Roesch; Elizabeth Barrett-Connor; John P Elder; Karla Espinosa de los Monteros; Smriti Shivpuri; Paul J Mills; Gregory A Talavera; Karen A Matthews
Journal:  Health Psychol       Date:  2011-11-07       Impact factor: 4.267

4.  Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women.

Authors:  C M Francucci; P Daniele; D Pantaleo; N Iori; A Camilletti; F Massi; M Boscaro
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

5.  Associations between nocturnal blood pressure dipping and the metabolic syndrome in high- vs. low-acculturated Mexican American women.

Authors:  Smriti Shivpuri; Matthew A Allison; Caroline A Macera; Suzanne Lindsay; Linda C Gallo
Journal:  Am J Hypertens       Date:  2013-05-03       Impact factor: 2.689

6.  Domains of chronic stress, lifestyle factors, and allostatic load in middle-aged Mexican-American women.

Authors:  Linda C Gallo; Jessica A Jiménez; Smriti Shivpuri; Karla Espinosa de los Monteros; Paul J Mills
Journal:  Ann Behav Med       Date:  2011-02

7.  The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

Authors:  C Finelli; P Crispino; S Gioia; N La Sala; L D'amico; M La Grotta; O Miro; D Colarusso
Journal:  EXCLI J       Date:  2016-02-23       Impact factor: 4.068

8.  Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes.

Authors:  Athena Philis-Tsimikas; Addie L Fortmann; Job G Godino; James Schultz; Scott C Roesch; Todd P Gilmer; Emilia Farcas; Haley Sandoval; Kimberly L Savin; Taylor Clark; Mariya Chichmarenko; Jennifer A Jones; Linda C Gallo
Journal:  Trials       Date:  2022-01-28       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.